19th Oct 2020 17:34
Shield Therapeutics PLC - London-based pharmaceutical company - Teva Pharmaceutical Industries Ltd has withdrawn its appeal against the European Patent Office's decision regarding patent 2668175 covering "Process for preparing an iron hydroxypyrone". Has also withdrawn opposition to patent 3160951 covering "Crystalline Forms of Ferric Maltol".
"We are delighted that the European Patent Office has decided not to continue proceedings following the withdrawal of the opposition by TEVA and saw no reason to amend the patent as originally granted. This publicly demonstrates the validity of the patent and the strength of defence that Shield provided to robustly defend its patents," said Lucy Huntington-Bailey, general counsel.
Current stock price: 137.50 pence
Year-to-date change: down 23%
By Dayo Laniyan; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Shield Thera